From ‘gills to pills’: urotensin-II as a regulator of mammalian cardiorenal function
- 1 February 2004
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 25 (2) , 76-85
- https://doi.org/10.1016/j.tips.2003.12.005
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- Urotensin II Acts Centrally to Increase Epinephrine and ACTH Release and Cause Potent Inotropic and Chronotropic ActionsHypertension, 2003
- Increased plasma urotensin II levels in patients with diabetes mellitusClinical Science, 2003
- Pharmacological characterization of SB‐710411 (Cpa‐c[D‐Cys‐Pal‐D‐Trp‐Lys‐Val‐Cys]‐Cpa‐amide), a novel peptidic urotensin‐II receptor antagonistBritish Journal of Pharmacology, 2002
- Urotensin II evokes potent vasoconstriction in humans in vivoBritish Journal of Pharmacology, 2002
- Lysophosphatidylcholine Potentiates the Mitogenic Effect of Various Vasoactive Compounds on Rabbit Aortic Smooth Muscle Cells.Japanese Heart Journal, 2002
- Human urotensin II increases coronary perfusion pressure in the isolated rat heart: Potentiation by nitric oxide synthase and cyclooxygenase inhibitionLife Sciences, 2001
- Inhibition of Insulin Release by Urotensin II - A Study on the Perfused Rat PancreasHormone and Metabolic Research, 2001
- Identification of Urotensin II as the Endogenous Ligand for the Orphan G-Protein-Coupled Receptor GPR14Biochemical and Biophysical Research Communications, 1999
- Urotensin II Is the Endogenous Ligand of a G-Protein-Coupled Orphan Receptor, SENR (GPR14)Biochemical and Biophysical Research Communications, 1999
- Potentiation of GABAA receptor-mediated Cl- current by urotensin peptides in identified Aplysia neuronsJournal of Neuroscience Research, 1999